Biocon Limited (NSE:BIOCON)
India · Delayed Price · Currency is INR 428.25
-2.00 (-0.46%)
May 25, 2026, 11:21 AM IST
Biocon Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Income | 3,856 | 10,133 | 10,225 | 4,627 | 6,484 |
Depreciation & Amortization | 19,567 | 16,403 | 15,341 | 11,131 | 8,142 |
Other Amortization | - | 467 | 347 | - | - |
Loss (Gain) From Sale of Assets | 158 | -10,497 | 12 | 52 | 23 |
Asset Writedown & Restructuring Costs | - | 86 | 3,945 | 470 | - |
Loss (Gain) From Sale of Investments | -1,632 | 415 | -7,008 | -1,978 | -146 |
Loss (Gain) on Equity Investments | - | - | 842 | 1,670 | 2,069 |
Stock-Based Compensation | 1,639 | 1,370 | 1,006 | 1,376 | 1,257 |
Provision & Write-off of Bad Debts | 529 | 290 | -171 | 64 | 248 |
Other Operating Activities | 7,145 | 12,715 | 11,352 | 6,123 | 1,584 |
Change in Accounts Receivable | 6,244 | 5,482 | -24,174 | 15,905 | -4,736 |
Change in Inventory | -9,178 | -3 | -8,864 | 8,862 | -4,140 |
Change in Accounts Payable | -1,917 | 5,808 | 29,365 | -37,359 | 1,618 |
Change in Other Net Operating Assets | -6,471 | -2,057 | -2,679 | 7,582 | -637 |
Operating Cash Flow | 19,940 | 40,612 | 29,539 | 18,525 | 11,766 |
Operating Cash Flow Growth | -50.90% | 37.49% | 59.46% | 57.45% | 1.46% |
Capital Expenditures | -17,979 | -21,366 | -16,805 | -15,960 | -16,978 |
Sale of Property, Plant & Equipment | - | 3 | 233 | 31 | 21 |
Cash Acquisitions | - | - | -5,532 | -156,645 | - |
Divestitures | - | 18,252 | - | 34,474 | - |
Sale (Purchase) of Intangibles | -1,138 | -2,067 | -2,511 | -1,303 | -2,270 |
Investment in Securities | -3,184 | 1,665 | 13,124 | -4,648 | 2,314 |
Other Investing Activities | 1,480 | 1,172 | 1,446 | 1,233 | -78 |
Investing Cash Flow | -20,821 | -2,341 | -10,045 | -142,818 | -16,991 |
Short-Term Debt Issued | 349 | 6,846 | 1,248 | 15,041 | 3,461 |
Long-Term Debt Issued | 2,664 | 96,582 | 13,718 | 109,399 | 10,701 |
Total Debt Issued | 3,013 | 103,428 | 14,966 | 124,440 | 14,162 |
Long-Term Debt Repaid | -49,703 | -99,087 | -28,096 | -395 | -11,070 |
Total Debt Repaid | -49,703 | -99,087 | -28,096 | -395 | -11,070 |
Net Debt Issued (Repaid) | -46,690 | 4,341 | -13,130 | 124,045 | 3,092 |
Issuance of Common Stock | 86,015 | 99 | 307 | 295 | 428 |
Repurchase of Common Stock | -26 | - | - | -647 | -3 |
Common Dividends Paid | -908 | -600 | -2,030 | -599 | - |
Other Financing Activities | -47,627 | -22,380 | -8,474 | 7,393 | -1,096 |
Financing Cash Flow | -9,236 | -18,540 | -23,327 | 130,487 | 2,421 |
Foreign Exchange Rate Adjustments | 1,994 | 312 | 29 | 217 | 33 |
Miscellaneous Cash Flow Adjustments | - | - | - | - | 338 |
Net Cash Flow | -8,123 | 20,043 | -3,804 | 6,411 | -2,433 |
Free Cash Flow | 1,961 | 19,246 | 12,734 | 2,565 | -5,212 |
Free Cash Flow Growth | -89.81% | 51.14% | 396.45% | - | - |
Free Cash Flow Margin | 1.16% | 12.61% | 8.63% | 2.30% | -6.37% |
Free Cash Flow Per Share | 1.43 | 16.06 | 10.64 | 2.15 | -4.36 |
Cash Interest Paid | 8,654 | 6,342 | 8,474 | 4,856 | 1,096 |
Cash Income Tax Paid | 2,426 | 4,596 | 2,923 | 2,286 | 2,620 |
Levered Free Cash Flow | -466.13 | -28,162 | 27,613 | 1,402 | -12,380 |
Unlevered Free Cash Flow | 5,723 | -22,614 | 33,703 | 4,021 | -11,958 |
Change in Working Capital | -11,322 | 9,230 | -6,352 | -5,010 | -7,895 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.